Jill Hardin, MS, PhD
Manager, Epidemiology Analytics Epidemiology
Janssen Research and Development
Jill Hardin is a Manager, Epidemiology Analytics Epidemiology at Janssen Research and Development, a Johnson & Johnson company. Her area of expertise includes epidemiologic analysis of patient populations in various therapeutic areas using observational claims data. She has also been working in the area of clinical trial feasibility, where she conducts studies examining the impact of clinical trial inclusion and exclusion criteria in observational data to assess the ability to recruit patient populations. At OHDSI she is co-leading a research study which aims at quantitatively describing treatment pathways of people with thyroid conditions.
Jill received an undergraduate degree in Chemistry from the University of Massachusetts, Dartmouth, a Masters of Business Administration from Santa Clara University, and a Master of Science and PhD in Epidemiology from University of California, Berkeley. Prior to Janssen R&D, Jill worked in the pharmaceutical industry in various roles, ranging from working in the areas of synthetic organic chemistry, high throughput screening, and software and database development prior to obtaining her PhD. After graduating she did her postdoctoral work in genetic epidemiology at UCSF and then returned to the pharmaceutical industry working at Gilead and Amgen prior to joining the Janssen team.